product complaints

R&D

As the life sciences field becomes more complex, it is apparent that many aspects of product quality and safety processes are inextricably linked

Events

Partner Content

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.